Table 3.
Characteristics of Responding Patients
| UPN | 2 | 17 | 19 | 21 | 34 | 42 | 46 |
|---|---|---|---|---|---|---|---|
| Age/Gender | 70/M | 21/M | 25/M | 21/M | 65/M | 38/M | 29/F |
| Diagnosis | Pre-B | Pre-B | Pre-B | Pre-B | Bi | Pre-B | Pre-T |
| Salvage # | 2 | 3 | 1 | 2 | 3 | 3 | 4 |
| CRD1 (m) | 0 | 13.3 | 5.2 | 6.4 | 10.7 | 0 | 0 |
| Karyotype | Complex | IM | Ph | Diploid | Diploid | Ph/-5/-7 | Diploid |
| Cycles to response | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Response | CR | CR | CR | BMCR | CR | CR | CRp |
| Response duration (d) | 44 | 29 | 43 | 46 | 55 | 57 | 89 |
UPN, unidentified patient number; Bi, biphenotypic acute leukemia; CRD1, duration of first complete remission (prior to study entry); IM, insufficient metaphases; Ph, Philadelphia chromosome; BMCR, marrow CR